Filed in archive
Drugs, Vaccines and Therapeutics
, Genomics, Proteomics and Bioinformatics
by ruth on August 8, 2007

In the current study, the researchers found that treatments that partially block the activity of liver enzymes called proprotein convertases decreased plasma HDL-C levels in mice. They showed that the metabolic effect of the proprotein convertases depended on yet another factor, an enzyme called endothelial lipase (EL), which breaks down HDL-C. Proprotein convertases normally reduce EL function, they reported. Thus, the loss of proprotein convertase activity leads to an increase in EL and a decline in HDL-C.
Likewise, they showed that increased activity of proprotein convertases in the liver gives a significant boost to the protective HDL-C
Further investigations are still necessary to determine if the same pathway applies to humans. The authors will also look for chemicals capable of modifying the pathway, which could hold promise as new good-cholesterol-boosting drugs.
Source: Science Daily
Image: The Maturation of HDL, Credit: Medscape
Tags:
cholesterol
good+cholesterol
heart+disease
cardiovascular+disease
biotech
proprotein+convertases
bio
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/85251
Mr Wong
Vote for Liver Proprotein Convertases Modulate HDL Metabolism:
|
Rating: 8.00 out of 5 vote(s) cast.
|
Response from:
universityupdate.com
Response from:
Ideas For Women News Blog
I’m a little late this week. Here’s what I think are the most interesting blog posts and news of the week:
Genes and DNA
Hsien-Hsien Lei wrote about a disease associated with aging: exfoliative glaucoma and how it has been discovered that ...
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







